_256_384.jpg)
Medical Device | November 01, 2021
Holborn Wells and SpeedBio India forms JV to manufacture in vitro diagnostics
Both parties are expected to invest a total of US $ 1 million to establish the brand
Both parties are expected to invest a total of US $ 1 million to establish the brand
The release of this batch will secure the supply for hospitals and cancer centres that are involved in the clinical trials managed by the company
The collaboration provides KardiaMobile users quick access to doctors worldwide for consultations about their ECG readings
Kymriah, the first-ever FDA-approved CAR-T cell therapy, is currently available in 30 countries in one or more indications
Acute therapies continue to report strong growth compared to chronic ones.
In India, MSD has signed non-exclusive licensing agreements with eight pharma companies.
The youngest child in India to survive ECMO after undergoing bone marrow transplant for a rare disease
This capability programme aims to upskill 5000 nurses across the country in the next year by converting the current modules into an e-learning one
Moderate-to-severe plaque psoriasis affects about 35 per cent of patients. A key challenge is that many treatments stop working overtime and symptoms return
The collaboration aims to deliver greater insights to the oncology fraternity, predict patient therapy responses and enable therapy selection resulting in optimal treatment outcomes.
Subscribe To Our Newsletter & Stay Updated
